Sequence Name |
Description |
Length |
Blast Hits |
min E-value |
Similarity |
GO hits |
GO names |
Enzyme Codes |
InterPro Scan |
contig03401 |
cdc5 cell division cycle 5-like |
323 |
20 |
9.17E-48 |
99.40% |
9 |
P:RNA splicing; F:DNA binding; C:spliceosomal complex; F:RNA binding; P:cell cycle; P:mRNA processing; P:protein targeting; P:regulation of transcription, DNA-dependent; P:cell division |
|
|
contig03402 |
cdc45 cell division cycle 45-like ( cerevisiae) |
913 |
20 |
1.83E-102 |
91.75% |
4 |
C:cytoplasm; P:DNA replication checkpoint; F:protein binding; C:nucleus |
|
|
contig03403 |
dynactin 4 |
368 |
20 |
2.20E-54 |
94.25% |
4 |
F:protein N-terminus binding; C:cytoplasmic dynein complex; C:centrosome; C:nucleus |
|
|
contig03404 |
ring finger protein 121 |
246 |
20 |
5.31E-24 |
75.00% |
2 |
F:metal ion binding; C:membrane |
|
|
contig03405 |
---NA--- |
345 |
0 |
|
|
0 |
|
|
|
contig03406 |
---NA--- |
805 |
0 |
|
|
0 |
|
|
|
contig03407 |
chromosome 15 open reading frame 24 |
478 |
20 |
2.90E-46 |
88.85% |
5 |
F:purine nucleotide binding; C:integral to membrane; C:extracellular space; C:cytoplasm; F:carbohydrate binding |
|
|
contig03408 |
adp-ribosylation factor-like 1 |
285 |
20 |
7.62E-26 |
100.00% |
8 |
F:enzyme activator activity; P:Golgi vesicle transport; F:GTP binding; P:Golgi organization; F:protein binding; C:trans-Golgi network; P:small GTPase mediated signal transduction; F:GTPase activity |
EC:3.6.5.1; EC:3.6.5.2; EC:3.6.5.3; EC:3.6.5.4 |
|
contig03409 |
acetyl propionyl beta subunit |
240 |
9 |
4.10E-16 |
80.89% |
1 |
F:ligase activity |
|
|
contig03410 |
mediator complex subunit 16 |
338 |
20 |
4.51E-15 |
92.85% |
3 |
F:receptor activity; ; P:transcription from RNA polymerase II promoter |
|
|
contig03411 |
---NA--- |
269 |
0 |
|
|
0 |
|
|
|
contig03412 |
---NA--- |
292 |
0 |
|
|
0 |
|
|
|
contig03413 |
subfamily member 21 |
466 |
20 |
2.04E-47 |
80.55% |
5 |
F:nucleic acid binding; C:intracellular; P:zinc ion transport; F:heat shock protein binding; F:zinc ion binding |
|
|
contig03414 |
---NA--- |
191 |
0 |
|
|
0 |
|
|
|
contig03415 |
taf5 rna polymerase tata box binding protein -associated factor |
265 |
20 |
5.75E-34 |
96.10% |
8 |
P:chromatin modification; P:transcription initiation from RNA polymerase II promoter; C:nucleolus; P:regulation of transcription, DNA-dependent; F:protein dimerization activity; F:transcription factor activity; F:histone acetyltransferase activity; C:transcription factor TFIID complex |
EC:2.3.1.48 |
|
contig03416 |
---NA--- |
274 |
0 |
|
|
0 |
|
|
|
contig03417 |
phenylalanyl-trna beta subunit |
719 |
20 |
5.13E-90 |
88.05% |
5 |
C:cytoplasm; F:phenylalanine-tRNA ligase activity; F:RNA binding; F:ATP binding; P:phenylalanyl-tRNA aminoacylation |
EC:6.1.1.20 |
|
contig03418 |
---NA--- |
214 |
0 |
|
|
0 |
|
|
|
contig03419 |
---NA--- |
102 |
0 |
|
|
0 |
|
|
|
contig03420 |
novel protein (zgc:153989) |
250 |
20 |
2.37E-24 |
86.45% |
1 |
C:mitochondrion |
|
|
contig03421 |
mps one binder kinase activator-like 1a |
988 |
20 |
4.75E-22 |
98.20% |
5 |
F:kinase activity; C:cytoplasm; C:nucleus; F:zinc ion binding; F:protein binding |
|
|
contig03422 |
---NA--- |
354 |
0 |
|
|
0 |
|
|
|
contig03423 |
kinetochore homolog |
167 |
20 |
4.12E-16 |
82.40% |
5 |
C:kinetochore; F:protein binding; P:mitosis; P:mitotic cell cycle checkpoint; P:cell division |
|
|
contig03424 |
---NA--- |
359 |
0 |
|
|
0 |
|
|
|
contig03425 |
---NA--- |
280 |
0 |
|
|
0 |
|
|
|
contig03426 |
---NA--- |
354 |
0 |
|
|
0 |
|
|
|
contig03427 |
methyltransferase like 8 |
431 |
20 |
3.60E-12 |
79.55% |
1 |
F:methyltransferase activity |
EC:2.1.1.0 |
|
contig03428 |
cdna sequence bc003266 |
348 |
16 |
5.78E-26 |
82.31% |
2 |
P:P; C:C |
|
|
contig03429 |
sorting nexin 22 |
291 |
7 |
5.08E-14 |
84.29% |
3 |
F:phosphoinositide binding; F:protein binding; P:cell communication |
|
|
contig03430 |
apg16 autophagy 16-like isoform 6 |
546 |
20 |
7.86E-90 |
98.05% |
4 |
P:protein transport; C:pre-autophagosomal structure membrane; P:autophagy; F:protein binding |
|
|
contig03431 |
---NA--- |
244 |
0 |
|
|
0 |
|
|
|
contig03432 |
coiled-coil-helix-coiled-coil-helix domain containing 1 |
476 |
20 |
2.25E-22 |
66.45% |
4 |
F:F; P:P; C:nucleus; C:C |
|
|
contig03433 |
parathyroid hormone-like hormone |
1156 |
20 |
5.09E-29 |
63.90% |
19 |
P:epithelial cell differentiation; P:cAMP metabolic process; P:skeletal system development; P:negative regulation of cell proliferation; P:positive regulation of cell proliferation; P:surfactant homeostasis; C:nucleus; P:cell-cell signaling; P:activation of adenylate cyclase activity by G-protein signaling pathway; P:epidermis development; C:extracellular space; F:calcium ion binding; P:lung alveolus development; F:hormone activity; C:cytoplasm; P:osteoblast development; P:female pregnancy; C:extracellular region; P:lactation |
|
|
contig03434 |
activating transcription factor 7 interacting protein |
272 |
2 |
4.26E-05 |
75.00% |
5 |
P:regulation of transcription, DNA-dependent; P:transcription termination; P:transcription; P:transcription antitermination; C:nucleus |
|
|
contig03435 |
unc-45 homolog a |
136 |
7 |
1.11E-05 |
83.00% |
9 |
P:skeletal muscle tissue development; C:nucleus; C:cytoplasm; P:multicellular organismal development; P:cell differentiation; C:C; F:protein binding; P:P; F:binding |
|
|
contig03436 |
---NA--- |
335 |
0 |
|
|
0 |
|
|
|
contig03437 |
glycosyltransferase 8 domain containing 1 |
274 |
20 |
5.69E-34 |
82.70% |
3 |
C:membrane attack complex; P:carbohydrate biosynthetic process; F:transferase activity, transferring hexosyl groups |
EC:2.4.1.0 |
|
contig03438 |
dihydrolipoamide s-succinyltransferase (e2 component of 2-oxo-glutarate complex) |
1286 |
20 |
1.05E-126 |
90.20% |
6 |
C:oxoglutarate dehydrogenase complex; F:dihydrolipoyllysine-residue succinyltransferase activity; F:protein binding; P:tricarboxylic acid cycle; F:lipoic acid binding; C:mitochondrion |
EC:2.3.1.61 |
|
contig03439 |
---NA--- |
338 |
0 |
|
|
0 |
|
|
|
contig03440 |
---NA--- |
287 |
0 |
|
|
0 |
|
|
|
contig03441 |
---NA--- |
260 |
0 |
|
|
0 |
|
|
|
contig03442 |
peptidoglycan recognition protein |
986 |
20 |
1.90E-55 |
69.00% |
3 |
P:defense response to bacterium; F:binding; F:N-acetylmuramoyl-L-alanine amidase activity |
EC:3.5.1.28 |
|
contig03443 |
---NA--- |
255 |
0 |
|
|
0 |
|
|
|
contig03444 |
---NA--- |
398 |
0 |
|
|
0 |
|
|
|
contig03445 |
---NA--- |
302 |
0 |
|
|
0 |
|
|
|
contig03446 |
---NA--- |
716 |
0 |
|
|
0 |
|
|
|
contig03447 |
wd repeat domain 40a |
356 |
20 |
1.04E-43 |
90.60% |
2 |
P:P; C:C |
|
|
contig03448 |
---NA--- |
252 |
0 |
|
|
0 |
|
|
|
contig03449 |
integral membrane protein 1 |
614 |
20 |
1.42E-62 |
100.00% |
6 |
C:extracellular space; C:membrane fraction; P:protein amino acid glycosylation; C:integral to membrane; F:dolichyl-diphosphooligosaccharide-protein glycotransferase activity; C:endoplasmic reticulum |
EC:2.4.1.119 |
|
contig03450 |
nuclear vcp-like |
363 |
20 |
6.93E-24 |
83.05% |
3 |
F:nucleoside-triphosphatase activity; F:ATP binding; C:nucleus |
EC:3.6.1.15 |
|
contig03451 |
ring finger protein 32 |
669 |
20 |
1.65E-52 |
59.20% |
2 |
C:endosome; C:aggresome |
|
|
contig03452 |
ring finger protein 7 |
754 |
20 |
6.49E-62 |
95.50% |
12 |
F:copper ion binding; P:induction of apoptosis by oxidative stress; F:zinc ion binding; P:zinc ion transport; ; P:anti-apoptosis; P:activation of caspase activity; P:apoptotic mitochondrial changes; F:protein binding; P:ubiquitin cycle; C:cytoplasm; C:nucleus |
|
|
contig03453 |
small inducible cytokine subfamily member 1 |
378 |
20 |
5.74E-34 |
80.85% |
11 |
P:negative regulation of endothelial cell proliferation; C:aminoacyl-tRNA synthetase multienzyme complex; P:cell-cell signaling; P:inflammatory response; P:negative regulation of angiogenesis; F:cytokine activity; P:leukocyte migration; F:cell surface binding; F:tRNA binding; F:protein homodimerization activity; P:defense response to virus |
|
|
contig03454 |
---NA--- |
258 |
0 |
|
|
0 |
|
|
|
contig03455 |
---NA--- |
285 |
0 |
|
|
0 |
|
|
|
contig03456 |
exosomal core protein csl4 |
577 |
20 |
5.64E-41 |
89.65% |
6 |
C:nucleolus; F:exonuclease activity; F:RNA binding; F:protein binding; P:rRNA processing; C:exosome (RNase complex) |
|
|
contig03457 |
wd repeat domain 4-like |
259 |
3 |
9.59E-21 |
67.00% |
0 |
|
|
|
contig03458 |
sfrs protein kinase 1 |
761 |
20 |
4.88E-65 |
69.85% |
11 |
F:protein serine/threonine kinase activity; P:intracellular protein kinase cascade; P:regulation of mRNA processing; P:chromosome segregation; P:RNA splicing; F:ATP binding; F:protein binding; F:magnesium ion binding; C:cytoplasm; C:nucleus; P:protein amino acid phosphorylation |
EC:2.7.11.0 |
|
contig03459 |
down syndrome critical region gene 3 |
317 |
20 |
2.14E-28 |
89.65% |
3 |
C:retromer complex; C:nucleus; P:vacuolar transport |
|
|
contig03460 |
---NA--- |
401 |
0 |
|
|
0 |
|
|
|
contig03461 |
haus augmin-like subunit 4 |
259 |
3 |
1.43E-16 |
82.33% |
2 |
F:F; C:C |
|
|
contig03462 |
---NA--- |
263 |
0 |
|
|
0 |
|
|
|
contig03463 |
alpha |
391 |
20 |
7.84E-52 |
98.95% |
8 |
C:cytoplasm; C:cytoskeleton; P:actin cytoskeleton organization; C:lamellipodium; F:actin binding; C:focal adhesion; P:cell adhesion; C:nucleus |
|
|
contig03464 |
---NA--- |
371 |
0 |
|
|
0 |
|
|
|
contig03465 |
---NA--- |
531 |
0 |
|
|
0 |
|
|
|
contig03466 |
phosphoglucomutase 1 |
904 |
20 |
4.51E-97 |
87.85% |
5 |
C:cytoplasm; P:cellular calcium ion homeostasis; P:glucose metabolic process; F:magnesium ion binding; F:phosphoglucomutase activity |
EC:5.4.2.2 |
|
contig03467 |
vacuolar protein sorting-associated protein 29 |
591 |
20 |
3.66E-89 |
99.15% |
6 |
C:endosome; P:Golgi to vacuole transport; C:membrane; F:zinc ion binding; F:phosphoserine phosphatase activity; P:protein transport |
EC:3.1.3.3 |
|
contig03468 |
---NA--- |
276 |
0 |
|
|
0 |
|
|
|
contig03469 |
---NA--- |
156 |
0 |
|
|
0 |
|
|
|
contig03470 |
---NA--- |
322 |
0 |
|
|
0 |
|
|
|
contig03471 |
---NA--- |
232 |
0 |
|
|
0 |
|
|
|
contig03472 |
meckel type 1 |
245 |
20 |
3.45E-23 |
69.90% |
2 |
P:P; C:C |
|
|
contig03473 |
janus kinase and microtubule interacting protein 1 |
573 |
20 |
7.92E-54 |
75.90% |
5 |
F:GABA receptor binding; F:RNA binding; P:transport; C:peripheral to membrane of membrane fraction; C:ribonucleoprotein complex |
|
|
contig03474 |
---NA--- |
450 |
0 |
|
|
0 |
|
|
|
contig03475 |
---NA--- |
305 |
0 |
|
|
0 |
|
|
|
contig03476 |
enoyl coenzyme a short mitochondrial |
452 |
20 |
2.11E-20 |
94.60% |
5 |
F:protein binding; F:long-chain-enoyl-CoA hydratase activity; C:mitochondrial matrix; P:fatty acid beta-oxidation; F:enoyl-CoA hydratase activity |
EC:4.2.1.74; EC:4.2.1.17 |
|
contig03477 |
---NA--- |
264 |
0 |
|
|
0 |
|
|
|
contig03478 |
uridine-cytidine kinase 1 |
507 |
20 |
1.21E-61 |
84.05% |
4 |
F:uridine kinase activity; P:metabolic process; F:ATP binding; F:phosphotransferase activity, alcohol group as acceptor |
EC:2.7.1.48; EC:2.7.1.0 |
|
contig03479 |
---NA--- |
271 |
0 |
|
|
0 |
|
|
|
contig03480 |
---NA--- |
324 |
0 |
|
|
0 |
|
|
|
contig03481 |
---NA--- |
298 |
0 |
|
|
0 |
|
|
|
contig03482 |
---NA--- |
309 |
0 |
|
|
0 |
|
|
|
contig03483 |
---NA--- |
261 |
0 |
|
|
0 |
|
|
|
contig03484 |
chromosome 9 open reading frame 156 |
895 |
20 |
2.34E-54 |
68.20% |
3 |
F:hydrolase activity; P:P; C:C |
|
|
contig03485 |
ewing sarcoma breakpoint region 1b |
1135 |
20 |
7.85E-43 |
86.70% |
7 |
C:cytoplasm; C:Cajal body; F:nucleic acid binding; P:mitosis; P:central nervous system neuron development; F:zinc ion binding; F:nucleotide binding |
|
|
contig03486 |
unnamed protein product [Tetraodon nigroviridis] |
324 |
3 |
7.51E-10 |
72.67% |
0 |
|
|
|
contig03487 |
---NA--- |
784 |
0 |
|
|
0 |
|
|
|
contig03488 |
membrane-associated ring finger 6 |
334 |
20 |
2.02E-39 |
76.55% |
3 |
F:metal ion binding; C:integral to membrane; C:endoplasmic reticulum |
|
|
contig03489 |
kiaa0528 protein |
252 |
20 |
1.70E-25 |
80.75% |
0 |
|
|
|
contig03490 |
---NA--- |
276 |
0 |
|
|
0 |
|
|
|
contig03491 |
---NA--- |
475 |
0 |
|
|
0 |
|
|
|
contig03492 |
---NA--- |
650 |
0 |
|
|
0 |
|
|
|
contig03493 |
insulin-degrading enzyme |
333 |
20 |
4.48E-47 |
96.45% |
9 |
C:soluble fraction; C:extracellular space; F:signal transducer activity; C:peroxisome; P:sex differentiation; P:signal transduction; F:insulysin activity; P:proteolysis; F:zinc ion binding |
EC:3.4.24.56 |
|
contig03494 |
fatty aldehyde dehydrogenase |
362 |
20 |
1.03E-51 |
84.00% |
10 |
F:3-chloroallyl aldehyde dehydrogenase activity; C:endoplasmic reticulum membrane; P:lipid metabolic process; P:central nervous system development; F:aldehyde dehydrogenase [NAD(P)+] activity; F:aldehyde dehydrogenase (NAD) activity; P:epidermis development; C:integral to membrane; P:peripheral nervous system development; P:cellular aldehyde metabolic process |
EC:1.2.1.5; EC:1.2.1.3 |
|
contig03495 |
---NA--- |
438 |
0 |
|
|
0 |
|
|
|
contig03496 |
acidic (leucine-rich) nuclear phosphoprotein 32 member b |
551 |
20 |
1.88E-14 |
97.00% |
5 |
P:nucleocytoplasmic transport; C:endoplasmic reticulum; C:perinuclear region of cytoplasm; C:nucleus; F:protein binding |
|
|
contig03497 |
ring finger protein 38 |
246 |
20 |
6.90E-40 |
94.40% |
2 |
F:zinc ion binding; F:protein binding |
|
|
contig03498 |
---NA--- |
251 |
0 |
|
|
0 |
|
|
|
contig03499 |
unnamed protein product [Tetraodon nigroviridis] |
491 |
1 |
4.74E-04 |
60.00% |
0 |
|
|
|
contig03500 |
actin related protein 2 3 complex subunit 2 |
126 |
20 |
1.42E-16 |
97.30% |
7 |
C:cytoplasm; P:cellular component movement; F:structural constituent of cytoskeleton; C:Arp2/3 protein complex; P:regulation of actin filament polymerization; F:actin binding; C:cell projection |
|
|
100 Rows returned.